Search Results - "IHLE, N. C"
-
1
Reduction−Alkylation Strategies for the Modification of Specific Monoclonal Antibody Disulfides
Published in Bioconjugate chemistry (01-09-2005)“…Site-specific conjugation of small molecules and enzymes to monoclonal antibodies has broad utility in the formation of conjugates for therapeutic, diagnostic,…”
Get full text
Journal Article -
2
Nonpeptide glycoprotein IIb/IIIa inhibitors. 8. Antiplatelet activity and oral antithrombotic efficacy of L-734,217
Published in The Journal of pharmacology and experimental therapeutics (01-07-1996)“…The antiplatelet activity of L-734,217, a nonpeptide platelet GPIIb/IIIa antagonist, was evaluated in the rat, guinea pig and dog. IC50 for inhibition of in…”
Get more information
Journal Article -
3
Nonpeptide alpha(v)beta(3) antagonists. 1. Transformation of a potent, integrin-selective alpha(IIb)beta(3) antagonist into a potent alpha(v)beta(3) antagonist
Published in Journal of medicinal chemistry (05-10-2000)“…Modification of the potent fibrinogen receptor (alpha(IIb)beta(3)) antagonist 1 generated compounds with high affinity for the vitronectin receptor…”
Get full text
Journal Article -
4
Nicotinamide N-oxides as CXCR2 antagonists
Published in Bioorganic & medicinal chemistry letters (23-07-2001)“…A series of nicotinamide N-oxides was synthesized and shown to be novel, potent, and selective antagonists of the CXCR2 receptor. Furthermore, these compounds…”
Get full text
Journal Article -
5
-
6
-
7
Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide
Published in Bioorganic & medicinal chemistry letters (07-01-2002)“…Mimetics of the RGD tripeptide are described that are potent, selective antagonists of the integrin receptor, alpha(v)beta(3). The use of the…”
Get full text
Journal Article -
8
Non-peptide fibrinogen receptor antagonists. 7. Design and synthesis of a potent, orally active fibrinogen receptor antagonist
Published in Journal of medicinal chemistry (18-08-1995)“…The design, synthesis, and pharmacological evaluation of L-734,217, a potent, low-molecular weight, orally active fibrinogen receptor antagonist, is reported…”
Get full text
Journal Article -
9
-
10
-
11
Nicotinanilides as inhibitors of neutrophil chemotaxis
Published in Bioorganic & medicinal chemistry letters (03-06-2002)“…A series of 4-fluoronicotinanilides was synthesized and shown to be novel, potent, and selective inhibitors against GRO-α-driven human neutrophil chemotaxis…”
Get full text
Journal Article -
12